Si prevede che il mercato dei dispositivi di autotrasfusione crescerà da 1.000,26 milioni di dollari nel 2021 a 1.331,99 milioni di dollari entro il 2028; si stima che crescerà a un CAGR del 4,2% dal 2021 al 2028.
Il trapianto di organi è una procedura chirurgica eseguita in caso di insufficienza d'organo. Di solito, il trapianto di organi viene effettuato per organi come cuore, fegato e reni; tuttavia, con l’aumento dei casi di malattie croniche, è necessario il trapianto di altri organi come polmoni, pancreas, cornea e tessuti vascolari. Queste procedure generalmente richiedono ore e comportano notevoli perdite di sangue; l'autotrasfusione è uno dei metodi più validi per prevenire la perdita di sangue. Secondo la United Network for Organ Sharing (UNOS), i trapianti di organi effettuati negli Stati Uniti sono in costante aumento, con oltre 41.000 trapianti eseguiti nel 2021. Allo stesso modo, secondo i dati del Registro mondiale dei trapianti, la Spagna ha rappresentato il 20% di tutte le donazioni di organi nel UE nel 2019 e il 6% delle donazioni mondiali. Il tasso di donatori di organi in Australia è migliorato negli ultimi anni, arrivando a 21,8 donatori per milione di abitanti nel 2019.Approfondimenti strategici
Analogamente, il Canada ha 22,2 donatori per milione di abitanti ed è costantemente in crescita miglioramento, in parte attribuito alla figura dei "Medici della donazione" - medici di terapia intensiva responsabili della donazione di organi. Secondo il Registro mondiale dei trapianti, nel 2019 la Cina ha avuto 5.818 donatori, ovvero 4,1 per milione di abitanti, mentre l'India ha avuto 715 donatori, ovvero 0,5 per milione di abitanti nel 2019. D'altro canto, la Russia ha registrato un tasso leggermente più elevato di 5,1 donatori per milione di abitanti. un milione di persone. Il partenariato pubblico-privato in collaborazione con i coordinatori dei trapianti ha dato un contributo significativo al miglioramento del trapianto di organi. Sia i paesi in via di sviluppo che quelli sviluppati hanno visto un aumento degli interventi chirurgici di trapianto di organi. Ad esempio, paesi in via di sviluppo come l’India e Singapore stanno emergendo come destinazioni del turismo medico nell’Asia del Pacifico. I paesi stanno facendo progressi in termini di fornitura di trattamenti medici migliori e avanzati. Pertanto, la crescente necessità di trapianto di organi è uno dei fattori chiave che guidano la domanda di strumenti diagnostici per i trapianti, come i dispositivi per l'autotrasfusione.
Il processo di autotrasfusione prevede la reinfusione del sangue del paziente. Il sangue viene raccolto dalla cavità peritoneale o dalla regione del torace. Il processo può essere eseguito prima dell'intervento chirurgico o durante e dopo l'intervento chirurgico utilizzando il sistema di autotrasfusione. Le procedure mediche, come la sostituzione articolare, gli interventi chirurgici alla colonna vertebrale e quelli cardiaci, tra gli altri, richiedono l'autotrasfusione. Aiuta a ridurre il rischio di infezione ed elimina anche i problemi e le complicazioni associati alla conservazione e alla somministrazione del sangue di donatori omologhi. Aiuta a prevenire la trasmissione nei pazienti di malattie trasmissibili per via ematica correlate alla trasfusione.
Approfondimenti di mercato
Sviluppi tecnologici nei dispositivi per autotrasfusione
I dispositivi per autotrasfusione vengono solitamente utilizzati durante interventi chirurgici di un'ora, come il trapianto di rene, e in caso di emergenza. Questi interventi sono associati al rischio di un’eccessiva perdita di sangue, il che rende difficile compensare la perdita di sangue con nuovo sangue, soprattutto in caso di gruppi sanguigni rari. A causa dell’ampia domanda, i principali attori nel mercato dei dispositivi di autotrasfusione offrono dispositivi di autotrasfusione avanzati e completamente automatizzati che riducono gli interventi umani. Ad esempio, nell'aprile 2021, B-Capta di LivaNova PLC è stato approvato dalla Food and Drug Administration statunitense. Durante complessi interventi chirurgici di bypass cardiopolmonare pediatrici e adulti, questo dispositivo aiuta nel monitoraggio rapido e accurato dei parametri venosi e dei gas sanguigni. Allo stesso modo, nell'aprile 2019, BD ha lanciato i suoi mezzi di controllo qualità BD BACTEC in tutto il mondo per aiutare a identificare le unità piastriniche contaminate durante le trasfusioni.
Inoltre, molte aziende hanno intrapreso attività strategiche come acquisizioni, partnership e altro per conquistare il mercato . Ad esempio, Medtronics ha acquisito AV Medical Technologies nell'ottobre 2019. Nel dicembre 2019, Getinge ha acquistato Applikon Biotechnology, leader globale nello sviluppo e nella fornitura di sistemi bioreattori innovativi dal laboratorio alla scala industriale. Pertanto, tali progressi probabilmente porteranno nuove tendenze nel mercato dei dispositivi di autotrasfusione nei prossimi anni.
Approfondimenti basati sull'applicazione
In base all'applicazione, il mercato dei dispositivi di autotrasfusione è segmentato in cardiaci interventi chirurgici, interventi chirurgici ortopedici, trapianti di organi, procedure traumatologiche e altri. Il segmento della chirurgia cardiaca ha detenuto la quota maggiore del mercato nel 2021, mentre si stima che anche il segmento dei trapianti di organi registrerà il CAGR più nel corso del 2021-2028
Gli operatori del mercato dei dispositivi per autotrasfusione adottano strategie organiche come il lancio e l'espansione del prodotto per espandere la propria presenza e il portafoglio di prodotti a livello globale e soddisfare la crescente domanda. Gli sviluppi delle aziende nel mercato dei dispositivi di autotrasfusione sono stati caratterizzati come sviluppi organici e inorganici. Diverse aziende si stanno concentrando su strategie organiche, come il lancio e l’espansione dei prodotti. Le strategie di crescita inorganica osservate nel mercato dei dispositivi di autotrasfusione sono state partnership e collaborazioni. Queste strategie di crescita hanno aiutato gli attori del mercato dei dispositivi di autotrasfusione nell’espansione delle loro attività e hanno rafforzato la loro presenza geografica. Inoltre, strategie di crescita come acquisizioni e partnership hanno contribuito a rafforzare la base di clienti e ad aumentare il portafoglio di prodotti. Le aziende hanno massimizzato la propria crescita con diverse strategie inorganiche per migliorare il valore di mercato dei dispositivi di autotrasfusione e la posizione nel mercato dei dispositivi di autotrasfusione. Gli sviluppi organici detengono il 66,67% del totale degli sviluppi strategici nel mercato dei dispositivi di autotrasfusione. Mentre le strategie inorganiche rappresentano il 33,33% della crescita delle aziende.
Il mercato dei dispositivi per autotrasfusione è stato segmentato come segue:
Il mercato dei dispositivi per autotrasfusione è segmentato in base al tipo, applicazione, e utente finale. In base alla tipologia, il mercato dei dispositivi per autotrasfusione è suddiviso in prodotti e accessori. Il mercato dei dispositivi per autotrasfusione, in base all'applicazione, è segmentato in interventi chirurgici cardiaci, interventi ortopedici, trapianti di organi, procedure traumatologiche e altri.
Il mercato dei dispositivi per autotrasfusione, in base all'utente finale, è suddiviso in ospedali, strutture specialistiche cliniche e centri chirurgici ambulatoriali.
Profili aziendali nel mercato dei dispositivi per autotrasfusione
- BD
- Braile Biomedica
- Fresenius SE & ; Co. KGaA
- Haemonetics Corporation
- LivaNova PLC
- Medtronic
- Redax SpA
- SARSTEDT AG e Co. KG
- Teleflex Incorporated
- Zimmer Biomet
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The accessories segment dominated the global autotransfusion devices market and held the largest revenue share of 55.66% in 2021.
The intraoperative autotransfusion systems segment dominated the global autotransfusion devices market and held the largest revenue share of 71.70% in 2021
Key factors that are driving the growth of this market are rapid increase in chronic diseases, rise in transplant, and difficulty in obtaining blood of rare groups.
The autotransfusion process involves the reinfusion of the patient's blood collected from the peritoneal cavity or thorax region. The process can be accomplished before surgery or during and after the surgery using the autotransfusion system. Medical procedures, such as joint replacement, spinal surgeries, and cardiac surgery require autotransfusion. It helps reduce the risk of infection, and abolishes the problems and complications associated with the banking and administration of homologous donor blood. It also prevents transmission of transfusion-related blood-borne diseases in patients.
The organ transplantation segment dominated the global autotransfusion devices market and held the largest revenue share of 3.22% in 2021.
The ambulatory surgery centers segment dominated the global autotransfusion devices market and accounted for the largest revenue share of 30.12% in 2021.
The autotransfusion devices market majorly consists of the players such as Medtronic; Fresenius SE & Co. KGaA; Teleflex Incorporated; BD; Zimmer Biomet; Braile Biomedica; Haemonetics Corporation; SARSTEDT AG and Co. KG; LivaNova PLC; Redax S.p.A. among others.
Global autotransfusion devices market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for autotransfusion devices. The US is estimated to hold the largest share in the autotransfusion devices market during the forecast period. The growth of the market is attributed to factors such as increasing prevalence of cancer in the US, and cancer awareness initiatives undertaken by local governments and global health organizations. In addition, growth involvement of rare blood groups, rising number of transplant procedures and rising prevalence of chronic diseases in the region stimulate the growth of autotransfusion devices market in North America. On the other hand, need for reinfusion of blood, and advancements in healthcare facilities and infrastructure in the Asia Pacific are expected to account for the fastest growth of the region during the coming years.
The List of Companies - Autotransfusion Devices Market
- Medtronic
- Fresenius SE & Co. KGaA
- Teleflex Incorporated
- BD
- Zimmer Biomet
- Braile Biomedica
- Haemonetics Corporation
- SARSTEDT AG and Co. KG
- LivaNova PLC
- Redax S.p.A.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Mar 2022
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Mar 2022
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2022
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2022
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2022
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2022
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2022
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Mar 2022
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)